Cargando…
Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis
One to six percent of patients with microscopic colitis are refractory to medical treatment. The effect of faecal microbiota transplantation (FMT) in active collagenous colitis (CC) has, to the best of our knowledge, never been reported before. Here, we report the effect of repeated FMT in a patient...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323457/ https://www.ncbi.nlm.nih.gov/pubmed/28275312 http://dx.doi.org/10.3748/wjg.v23.i7.1319 |
_version_ | 1782510025884827648 |
---|---|
author | Günaltay, Sezin Rademacher, Lech Hultgren Hörnquist, Elisabeth Bohr, Johan |
author_facet | Günaltay, Sezin Rademacher, Lech Hultgren Hörnquist, Elisabeth Bohr, Johan |
author_sort | Günaltay, Sezin |
collection | PubMed |
description | One to six percent of patients with microscopic colitis are refractory to medical treatment. The effect of faecal microbiota transplantation (FMT) in active collagenous colitis (CC) has, to the best of our knowledge, never been reported before. Here, we report the effect of repeated FMT in a patient with CC. The patient presented with severe symptoms including profuse diarrhea and profound weight loss. Although she responded to budesonide in the beginning, she became gradually refractory to medical treatment, and was therefore treated with FMT. The patient remained in remission for 11 mo after the third faecal transplantation. The immunomodulatory effect of the therapy was evaluated using flow cytometry, which showed alterations in the profile of intraepithelial and lamina propria lymphocyte subsets after the second transplantation. Our observations indicate that FMT can have an effect in CC, which support the hypothesis that luminal factors, influencing the intestinal microbiota, are involved in the pathogenesis of CC. |
format | Online Article Text |
id | pubmed-5323457 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-53234572017-03-08 Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis Günaltay, Sezin Rademacher, Lech Hultgren Hörnquist, Elisabeth Bohr, Johan World J Gastroenterol Case Report One to six percent of patients with microscopic colitis are refractory to medical treatment. The effect of faecal microbiota transplantation (FMT) in active collagenous colitis (CC) has, to the best of our knowledge, never been reported before. Here, we report the effect of repeated FMT in a patient with CC. The patient presented with severe symptoms including profuse diarrhea and profound weight loss. Although she responded to budesonide in the beginning, she became gradually refractory to medical treatment, and was therefore treated with FMT. The patient remained in remission for 11 mo after the third faecal transplantation. The immunomodulatory effect of the therapy was evaluated using flow cytometry, which showed alterations in the profile of intraepithelial and lamina propria lymphocyte subsets after the second transplantation. Our observations indicate that FMT can have an effect in CC, which support the hypothesis that luminal factors, influencing the intestinal microbiota, are involved in the pathogenesis of CC. Baishideng Publishing Group Inc 2017-02-21 2017-02-21 /pmc/articles/PMC5323457/ /pubmed/28275312 http://dx.doi.org/10.3748/wjg.v23.i7.1319 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Case Report Günaltay, Sezin Rademacher, Lech Hultgren Hörnquist, Elisabeth Bohr, Johan Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis |
title | Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis |
title_full | Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis |
title_fullStr | Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis |
title_full_unstemmed | Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis |
title_short | Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis |
title_sort | clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323457/ https://www.ncbi.nlm.nih.gov/pubmed/28275312 http://dx.doi.org/10.3748/wjg.v23.i7.1319 |
work_keys_str_mv | AT gunaltaysezin clinicalandimmunologiceffectsoffaecalmicrobiotatransplantationinapatientwithcollagenouscolitis AT rademacherlech clinicalandimmunologiceffectsoffaecalmicrobiotatransplantationinapatientwithcollagenouscolitis AT hultgrenhornquistelisabeth clinicalandimmunologiceffectsoffaecalmicrobiotatransplantationinapatientwithcollagenouscolitis AT bohrjohan clinicalandimmunologiceffectsoffaecalmicrobiotatransplantationinapatientwithcollagenouscolitis |